...
首页> 外文期刊>Indian Journal of Ophthalmology >Clear lens extraction for patients who are unfit for laser-assisted in situ keratomileusis and implantable contact lenses in central Indian population
【24h】

Clear lens extraction for patients who are unfit for laser-assisted in situ keratomileusis and implantable contact lenses in central Indian population

机译:透明镜片提取用于在中央印度人口中不合适辅助激光辅助的患者的患者

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The purpose of this study is to establish the safety of clear lens extraction (CLE) for the correction of high myopia in patients unfit for implantable contact lenses (ICLs) and laser in situ keratomileusis in the central Indian population. Methods: In this retrospective observational study performed at a tertiary care centre, medical records of the patients who had undergone CLE with implantation of intraocular lens (IOL) to treat high myopia were retrieved. Details of the demographic profile, surgical procedure, complications, power, and type of IOLs implanted were recorded. Results: The average postoperative follow-up period was 64.1 ± 4.2 months. The average postoperative spherical power was ?1.4 ± 0.6 D, which was much lower than the preoperative spectacle power -15 ± 4.4 D. There was improvement in the postoperative visual acuity (0.4 ± 0.2 logMAR) from the preoperative distant uncorrected visual acuity (0.8 ± 0.2 logMAR). No significant change in intraocular pressure (IOP) was observed. The postoperative average anterior chamber depth (ACD) (2.66 ± 0.1 mm) was significantly deeper than the preoperative ACD (2.61 ± 0.1 mm) P = 0.00. Barrage laser was required for lattice degeneration in one patient before CLE and in two patients during follow-up. Two patients (8.7%) required Nd:YAG capsulotomy for posterior capsular opacification. None of the patients had corneal decompensation, retinal detachment, or endophthalmitis. Conclusion: CLE with implantation of IOL is the safe procedure for correcting high myopia in patients who are unfit for ICL. None of the patient had eye loss in the follow-up period of 5 years. The low incidence of complications can be attributable to the closed chamber lens removal and implantation of IOL and prophylactic retinal treatment.
机译:目的:本研究的目的是建立透明镜片提取(CLE)的安全性,以便在患者不适用于植入隐形眼镜(ICL)和激光在中央印度人口中的患者中的高近视。方法:在第三次护理中心进行的这项回顾性观察研究中,检测到植入眼内晶状体(IOL)植入治疗高近视的患者的病程。记录了人口统计学分布,外科手术,并发症,动力和IOL的类型的详细信息。结果:平均术后随访时间为64.1±4.2个月。平均术后球形是?1.4±0.6d,远低于术前眼镜电源-15±4.4d。从术前远处未矫正视力(0.8)的术后视力(0.4±0.2 logmar)有所改善(0.8 ±0.2 logmar)。观察到眼压(IOP)没有显着变化。术后平均前室深度(ACD)(2.66±0.1mm)显着深度比术前ACD(2.61±0.1mm)P = 0.00。在随访期间,在CLE和两名患者之前,在一个患者中需要屏障激光需要粘附激光。两名患者(8.7%)所需的Nd:YAG胶囊晶状体用于后囊透明度。患者均未出现角膜代样,视网膜脱离或眼球炎。结论:植入IOL的CLE是纠正ICL不适合的患者高近视的安全程序。在5年的后续期间,患者没有任何眼睛损失。低发病率可归因于闭合室镜片去除和植入IOL和预防视网膜处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号